Pages that link to "Q33617751"

The following pages link to Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk (Q33617751):

Displaying 37 items.

• Antidepressant-Warfarin Interaction and Associated Gastrointestinal Bleeding Risk in a Case-Control Study (Q28478738) (← links)
• Comparison of the Risk of Gastrointestinal Bleeding among Different Statin Exposures with Concomitant Administration of Warfarin: Electronic Health Record-Based Retrospective Cohort Study (Q28552407) (← links)
• The quality of Medicaid and Medicare data obtained from CMS and its contractors: implications for pharmacoepidemiology (Q33608853) (← links)
• Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (Q34252907) (← links)
• Risk of severe upper gastrointestinal complications among oral bisphosphonate users (Q35069355) (← links)
• Oral bisphosphonates do not increase the risk of severe upper gastrointestinal complications: a nested case-control study (Q35084489) (← links)
• Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors (Q35126153) (← links)
• A review of time courses and predictors of lipid changes with fenofibric acid-statin combination (Q36011053) (← links)
• Improving medical record retrieval for validation studies in Medicare data. (Q36333473) (← links)
• Improving postapproval drug safety surveillance: getting better information sooner (Q36367834) (← links)
• Pharmacoepidemiologic Methods for Studying the Health Effects of Drug-Drug Interactions (Q36483976) (← links)
• Bleeding complications and liver injuries during phenprocoumon treatment: a multicentre prospective observational study in internal medicine departments (Q36785642) (← links)
• Incidence rate and pattern of clinically relevant potential drug-drug interactions in a large outpatient population of a developing country (Q37129099) (← links)
• VKORC1 and CYP2C9 polymorphisms related to adverse events in case-control cohort of anticoagulated patients (Q37552063) (← links)
• Potential statin-drug interactions: prevalence and clinical significance (Q37724896) (← links)
• Drug and dietary interactions of warfarin and novel oral anticoagulants: an update (Q37848142) (← links)
• Co-Prescribing of Potentially Interacting Drugs during Warfarin Therapy - A Population-Based Register Study. (Q38417110) (← links)
• Mechanism of Drug-Drug Interactions Between Warfarin and Statins. (Q38776313) (← links)
• Analysis of the first therapeutic-target-achieving time of warfarin therapy and associated factors in patients with pulmonary embolism (Q39326279) (← links)
• Gastrointestinal bleeding and intracranial hemorrhage in concomitant users of warfarin and antihyperlipidemics. (Q40456654) (← links)
• Statin therapy and gastrointestinal hemorrhage: a retrospective cohort study with propensity score-matching (Q40815545) (← links)
• Non-traumatic compartment syndrome secondary to deep vein thrombosis and anticoagulation (Q41891773) (← links)
• Anticoagulation for noncardiac indications in neurologic patients: comparative use of non-vitamin k oral anticoagulants, low-molecular-weight heparins, and warfarin (Q47448340) (← links)
• A clinically significant interaction between warfarin and simvastatin is unique to carriers of the CYP2C9*3 allele (Q47750759) (← links)
• Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System. (Q48273359) (← links)
• Nonsteroidal anti-inflammatory drug choice and adverse outcomes in clopidogrel users: A retrospective cohort study. (Q52655970) (← links)
• The influence of genetic polymorphisms and interacting drugs on initial response to warfarin in Chinese patients with heart valve replacement (Q53159003) (← links)
• The Role of Clinical Variables and VKORC1 Polymorphism in Efficacy and Stability of Acenocoumarol in Neurological Patients. (Q54090336) (← links)
• Long-Term Statin Administration Does Not Affect Warfarin Time in Therapeutic Range in Australia or Singapore. (Q55110646) (← links)
• Statins and gastroduodenal endoscopic lesions: A case-control study (Q61447265) (← links)
• Risk factors of vitamin K antagonist overcoagulation (Q84863402) (← links)
• Comment on: "Desideratum for evidence-based epidemiology" (Q86299266) (← links)
• The influence of fibrate initiation on INR and warfarin dose in patients receiving chronic warfarin therapy (Q88432031) (← links)
• Bleeding events attributable to concurrent use of warfarin and other medications in high-risk elderly: meta-analysis and Italian population-based investigation (Q88599305) (← links)
• Frailty and Co-Prescribing of Potentially Interacting Drugs in New Users of Warfarin (Q90140661) (← links)
• Clopidogrel Drug Interactions and Serious Bleeding: Generating Real-World Evidence via Automated High-Throughput Pharmacoepidemiologic Screening (Q92149150) (← links)
• Sulfonylureas and metformin were not associated with an increased rate of serious bleeding in warfarin users: a self-controlled case series study (Q94553868) (← links)